pharma · Patency of the Ductus Arteriosus · Atopic Dermatitis · CNTB
S.L
S.L is a pharma organization headquartered in SAN DIEGO, CA, EU. It trades on NYSE under ticker CNTB. Primary therapeutic focus areas include Patency of the Ductus Arteriosus, Atopic Dermatitis, Chronic Rhinosinusitis Wi
SAN DIEGO, CA, EU HQ
Public company Type
CNTB · NYSE Ticker
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, EU
- Programs
- 15
- Drugs
- 11
- Patents
- 179
Rademikibart in prefilled syringe
Phase 2 · other · Asthma Acute
Rademikibart in prefilled syringe for Asthma Acute is a Phase 2 program (other) at S.L with 1 ClinicalTrials.gov record(s).
Internal code CBP-201-206
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- S.L
- Phase
- Phase 2
- Modality
- other
- Indication
- Asthma Acute
- Status
- active
- Trials
- 1